Prolonged conservative care versus early surgery in patients with sciatica from lumbar disc herniation: Cost utility analysis alongside a randomised controlled trial

BMJ

Volumn 336, Issue 7657, 2008, Pages 1351-1354

  Van Den Hout, Wilbert B ^a   Peul, Wilco C ^a,b   Koes, Bart W ^c   Brand, Ronald ^a   Kievit, Job ^a   Thomeer, Ralph T W M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADULT; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST OF ILLNESS; COST UTILITY ANALYSIS; FEMALE; HEALTH CARE; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; ISCHIALGIA; LUMBAR DISK HERNIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SURGICAL APPROACH; TREATMENT DURATION; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AGED; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; INTERVERTEBRAL DISK DISPLACEMENT; MIDDLE AGED; NETHERLANDS; QUALITY-ADJUSTED LIFE YEARS; SCIATICA;

EID: 46249122958     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39583.709074.BE     Document Type: Article

References (24)

1. Peul WC, van Houwelingen HC, Van den Hout WB, Brand R, Eekhof JA, Tans JT, et al. Prolonged conservative treatment or 'early' surgery in sciatica caused by a lumbar disc herniation: rationale and design of a randomized trial [ISRCT 26872154]. BMC Musculoskelet Disord 2005;6:8.
2. Peul WC, van Houwelingen HC, Van den Hout WB, Brand R, Eekhof JA, Tans JT, et al. Surgery versus prolonged conservative treatment for sciatica. N Engl J Med 2007;356:2245-56.
3. Peul WC, Van den Hout WB, Brand R, Thomeer RT, Koes BW, for the Leiden-The Hague Spine-Intervention-Prognostic-Study Group. Prolonged conservative care versus early surgery in patients with sciatica caused by lumbar disc herniation: two year results of a randomised controlled trial. BMJ 2008;10.1136/bmj.a143.
4. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
5. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095-108.
6. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 2005;43:203-20.
7. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:271-92.
8. Stiggelbout AM, Eijkemans MJ, Kiebert GM, Kievit J, Leer JW, Haes HJd. The 'utility' of the visual analog scale in medical decision making and technology assessment. Is it an alternative to the time trade-off? Int J Technol Assess Health Care 1996;12:291-8.
9. Statistics Netherlands. Consumer price index. May 2008. www.cbs.nl.
10. Briggs A, Clark T, Wolstenholme J, Clarke P. Missing . . . presumed at random: cost-analysis of incomplete data. Health Econ 2003;12:377-92.
11. Oostenbrink JB, Koopmanschap MA, Rutten FFH. Manual for cost analyses, methods and standard prices for economic evaluations in healthcare. [In Dutch.] Amstelveen: Dutch Health Insurance Executive Board, 2004.
12. Oostenbrink JB, Koopmanschap MA, Rutten FF. Standardisation of costs: the Dutch manual for costing in economic evaluations. Pharmacoeconomics 2002;20:443-54.
13. Dutch Health Insurance Executive Board. Pharmacotherapeutic compass. August 2006. [In Dutch.] www.fk.cvz.nl.
14. Van den Berg B, Brouwer W, van Exel J, Koopmanschap M. Economic valuation of informal care: the contingent valuation method applied to informal caregiving. Health Econ 2005;14:169-83.
15. Zethraeus N, Johannesson M, Jonsson B, Lothgren M, Tambour M. Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies. Pharmacoeconomics 2003;21:39-48.
16. Smulders YM, Thijs A. The cost per year of life gained: trends and internal contradictions. [In Dutch.] Ned Tijdschr Geneeskd 2006;150:2467-70.
17. Ubel PA, Hirth RA, Chernew ME, Fendrick AM. What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med 2003;163:1637-41.
18. Malter AD, Larson EB, Urban N, Deyo RA. Cost-effectiveness of lumbar discectomy for the treatment of herniated intervertebral disc. Spine 1996;21:1048-54.
19. Hansson E, Hansson T. The cost-utility of lumbar disc herniation surgery. Eur Spine J 2007;16:329-37.
20. Weber H. The effect of delayed disc surgery on muscular paresis. Acta Orthop Scand 1975;46:631-42.
21. Koes BW, van Tulder MW, Peul WC. Diagnosis and treatment of sciatica. BMJ 2007;334:1313-7.
22. Österman H, Seitsalo S, Karppinen J, Malmivaara A. Effectiveness of microdiscectomy for lumbar disc herniation: a randomized controlled trial with 2 years of follow-up. Spine 2006;31:2409-14.
23. Weinstein JN, Tosteson TD, Lurie JD, Tosteson AN, Hanscom B, Skinner JS, et al. Surgical vs nonoperative treatment for lumbar disk herniation: the spine patient outcomes research trial (SPORT): a randomized trial. JAMA 2006;296:2441-50.
24. Weinstein JN, Lurie JD, Tosteson TD, Skinner JS, Hanscom B, Tosteson AN, et al. Surgical vs nonoperative treatment for lumbar disk herniation: the spine patient outcomes research trial (SPORT) observational cohort. JAMA 2006;296:2451-9.